Aim: This study was aimed to screen the common genes between celiac disease (CD) and type 1 diabetes mellitus to find critical ones.
Background: Celiac disease as a chronic autoimmune disorder that is correlated to type 1 diabetes mellitus (T1DM) in several molecular pathways. Achieve to the clear common molecular mechanism of the both diseases is attracted attention of scientists.
Methods: The related genes to the CD and T1DM were obtained from disease query of STRING and included in two separated PPI networks by Cytoscape software version 3.7.1. The networks were analyzed by network analyzer and the hub nodes were determined. The common hubs between the two networks were selected for more analysis and enriched via gene ontology by using ClueGO plugin of Cytoscape software and action map was provided by Cluepedia application of Cytoscape software.
Results: Two separated networks of 2000 and 430 genes related to T1DM and CD, respectively were constructed. Numbers of 84 and 28 hubs were determined for T1DM and CD, respectively. There are 11 common hubs between the two networks. The first top hubs of Type 1 Diabetes Mellitus and CD networks were insulin (INS) and tumor necrosis factor (TNF), respectively. Number of 77 biological terms and pathways (in five clusters) were related to the common hubs. Action map revealed near relationship between hubs.
Conclusion: The result of this study indicated that TNF is key mediator of immune reactions in celiac disease and type 1 diabetes mellitus.
Green PH, Cellier CJNejom. Celiac disease. 2007;357(17):1731-43.
Izadi F, Tavirani MR, Honarkar Z, Rostami-Nejad MJG, bench hfbt. Celiac disease and hepatitis C relationships in transcriptional regulatory networks. 2017;10(4):303.
Ch'ng CL, Jones MK, Kingham JGC. Celiac disease and autoimmune thyroid disease. Clinical medicine & research. 2007;5(3):184-92.
Bibbò S, Pes GM, Usai-Satta P, Salis R, Soro S, Quarta Colosso BM, et al. Chronic autoimmune disorders are increased in coeliac disease: A case-control study. Medicine. 2017;96(47):e8562-e.
Assa A, Frenkel-Nir Y, Tzur D, Katz LH, Shamir R. Large population study shows that adolescents with celiac disease have an increased risk of multiple autoimmune and nonautoimmune comorbidities. Acta paediatrica (Oslo, Norway : 1992). 2017;106(6):967-72.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. 2008;359(26):2767-77.
Dretzke J, Cummins C, Sandercock J, Fry-Smith A, Barrett T, Burls A. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. NIHR Health Technology Assessment programme: Executive Summaries: NIHR Journals Library; 2004.
MACKAY JR, ROSEN FS, DAVIDSON A, DIAMOND BJTNEjom. Autoimmune diseases. 2001;345(5):340-50.
Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. 2005;128(4):S57-S67.
Gillett P, Gillett H, Israel D, Metzger D, Stewart L, Chanoine J, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. 2001;15(5):297-301.
Volta U, Tovoli F, Caio GJErog, hepatology. Clinical and immunological features of celiac disease in patients with type 1 diabetes mellitus. 2011;5(4):479-87.
Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, et al. Other complications and associated conditions. 2007;8(3):171-6.
Husby S, Koletzko S, Korponay-Szabo I, Mearin M, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. 2012;54(1):136-60.
Hermann R, Turpeinen H, Laine A, Veijola R, Knip M, Simell O, et al. HLA DR‐DQ‐encoded genetic determinants of childhood‐onset type 1 diabetes in Finland: an analysis of 622 nuclear families. 2003;62(2):162-9.
Kumar V, Wijmenga C, Withoff S, editors. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Seminars in immunopathology; 2012: Springer.
Knip M, Simell OJCSHpim. Environmental triggers of type 1 diabetes. 2012;2(7):a007690.
Kupfer SS, Jabri BJGEC. Pathophysiology of celiac disease. 2012;22(4):639-60.
Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. 2003;290(13):1713-20.
Rezaei-Tavirani M, Tavirani MR, Azodi MZ. The bioinformatics aspects of gene screening of HT-29, human colon cell line treated with caffeic acid. Gastroenterology and hepatology from bed to bench. 2019;12(3):246.
Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ. 2016;4:e2775.
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. The Journal of clinical investigation. 2012;122(4):1339-53.
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. science. 2006;314(5804):1461-3.
Yang A, Chen Y, Scherl E, Neugut AI, Bhagat G, Green PH. Inflammatory bowel disease in patients with celiac disease. Inflammatory bowel diseases. 2005;11(6):528-32.
Moller DE. Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology & Metabolism. 2000;11(6):212-7.
Barone MV, Zanzi D, Maglio M, Nanayakkara M, Santagata S, Lania G, et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One. 2011;6(2):e17039.
Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immune responses in celiac disease. Immunology letters. 2005;99(2):141-5.
Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends in Endocrinology & Metabolism. 2008;19(1):10-6.
Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC medicine. 2011;9(1):23.
Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nature genetics. 2010;42(4):295.
Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nature Reviews Nephrology. 2016;12(1):13.
Santin I, Castellanos‐Rubio A, Hualde I, Castaño L, Vitoria J, Bilbao J. Toll‐like receptor 4 (TLR4) gene polymorphisms in celiac disease. Tissue Antigens. 2007;70(6):495-8.
Liu F, Lu W, Qian Q, Qi W, Hu J, Feng B. Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease. BioMed Research International. 2012;2012.
Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Human immunology. 2009;70(2):121-4.
Chang DC, Xu X, Ferrante AW, Krakoff J. Reduced plasma albumin predicts type 2 diabetes and is associated with greater adipose tissue macrophage content and activation. Diabetology & metabolic syndrome. 2019;11(1):14.
Pham‐Short A, C. Donaghue K, Ambler G, K. Chan A, Hing S, Cusumano J, et al. Early elevation of albumin excretion rate is associated with poor gluten‐free diet adherence in young people with coeliac disease and diabetes. Diabetic Medicine. 2014;31(2):208-12.